Search Results

You are looking at 21 - 30 of 1,309 items for :

  • "characteristics" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access

Alexandre Hikiji Watanabe, Connor Willis, Melissa Pavilack-Kirker, Clara Lam, Leah Park, Sandhya Mehta, Jackie Kwong, Anindit Chhibber, Hillevi Bauer, Sabrina Ilham, Diana Brixner, and David Stenehjem

240 (46.0%) were HER2-low, 142 (27.2%) HER2+, 46 (8.8%) HER2 IHC 0, and 94 (18.0%) had unknown/incomplete HER2 results. Among the HER2-low patients, 198 (82.5%) were HR+, 40 (16.7%) were HR-, and 2 (0.8%) were unknown. The tumor characteristics and

Full access

Claire de Oliveira, Joyce Cheng, Kelvin Chan, Craig C. Earle, Murray Krahn, and Nicole Mittmann

and identified patient and system characteristics associated with high system costs after cancer treatment. The most common trajectory consisted of patients who were low-cost in the year before cancer treatment and remained low-cost after completing

Full access

Sevinj E. Rahimzade, Jamil A. Aliyev, Elkhan E. Kazimov, Leylakhanum A. Melikova, Konul S. Mardanova, Turkan E. Mansurova, and Elchin B. Mansurov

gynecological anamnesis characteristics in Azerbaijani women with BC and investigation of the prognostic significance of the relationship with the stage (S) of BC and biological subtypes (BS). Materials: 570 randomly selected women with BC were included in the

Full access

Nirmala K. Manjappachar, John A. Cuenca, Claudia M. Ramírez, Mike Hernandez, Peyton Martin, Maria P. Reyes, Alba J. Heatter, Cristina Gutierrez, Nisha Rathi, Charles L. Sprung, Kristen J. Price, and Joseph L. Nates

bias. We also excluded all postsurgical patients. Data Sources and Measurements Demographic and clinical information such as age, sex, comorbidities, Charlson comorbidity index (CCI), and characteristics of cancer, such as cancer diagnosis

Full access

Yao Zhu, Yu Wei, Hao Zeng, Yonghong Li, Chi-Fai Ng, Fangjian Zhou, Caiyun He, Guangxi Sun, Yuchao Ni, Peter K.F. Chiu, Jeremy Y.C. Teoh, Beihe Wang, Jian Pan, Fangning Wan, Bo Dai, Xiaojian Qin, Guowen Lin, Hualei Gan, Junlong Wu, and Dingwei Ye

), but detailed clinical characteristics were not available for patients from the commercial laboratory. Patients from the laboratory were offered germline sequencing, according to the genetic testing recommendations in the NCCN Clinical Practice

Full access

Benjamin R. Roman, Snehal G. Patel, Marilene B. Wang, Anna M. Pou, F. Christopher Holsinger, David Myssiorek, David Goldenberg, Samuel Swisher-McClure, Alexander Lin, Jatin P. Shah, and Judy A. Shea

-level factors related to the decision to use surveillance imaging are not well understood. Several studies have found that physician demographic and practice characteristics correlate with surveillance testing use in breast and colon cancers. 7 , 10 , 11

Full access

Benjamin L. Franc, Timothy P. Copeland, Robert Thombley, Miran Park, Ben Marafino, Mitzi L. Dean, W. John Boscardin, Hope S. Rugo, David Seidenwurm, Bhupinder Sharma, Stephen R. Johnston, and R. Adams Dudley

included in the study when the claim included an indication of breast cancer (ICD-9 codes 174.0–174.9). Patient characteristics examined included age group, whether RT was received, whether hormonal therapy was received, payer class, and MSA. Patients

Full access

Jessica S.W. Borgers, Richard P. Tobin, Robert J. Torphy, Victoria M. Vorwald, Robert J. Van Gulick, Carol M. Amato, Dasha T. Cogswell, Tugs-Saikhan Chimed, Kasey L. Couts, Adrie Van Bokhoven, Christopher D. Raeburn, Karl D. Lewis, Joshua Wisell, Martin D. McCarter, Rao R. Mushtaq, and William A. Robinson

stage IV disease without AGMs were identified. Patients without a valid research consent, incomplete medical records, or inadequate follow-up information were excluded. The following patient and tumor characteristics were collected from electronic

Full access

Ali Mokdad, Travis Browning, John C. Mansour, Hao Zhu, Amit G. Singal, and Adam C. Yopp

on characteristic radiographic imaging on dynamic contrasted-enhanced CT or MRI. Most of these diagnostic imaging studies are ordered by primary care physicians, who are at the beginning of the cancer care continuum and must not only discern an

Full access

Dingcheng Shen, Xiaolin Wang, Heng Wang, Gaopo Xu, Yumo Xie, Zhuokai Zhuang, Ziying Huang, Juan Li, Jinxin Lin, Puning Wang, Meijin Huang, Yanxin Luo, and Huichuan Yu

Cancer Staging Manual 26 based on pelvic MRI and CT imaging. Figure 1. (A) Patient flow and (B) the timeline for the longitudinal analysis in this study. Patients were grouped based on CEA level and recurrent status. The clinical characteristics